Infectious Disease Doctors in Saint Clairsville, OH Accepting Medicare

1 Infectious Disease doctors found. Showing 1 - 1

Viswanathan Chokkavelu, MD,FACP,FCCP Internal Medicine - Infectious Disease Medicare: Medicare Enrolled Practice Location: 100 N Sugar St, Saint Clairsville, OH 43950 Phone: 740-695-4400    Fax: 740-695-4148

News Archive

Myostatin shows promise for muscular dystrophy

Myostatin, a protein that blocks muscle growth, has shown promising results as a potential therapeutic target for treating muscular dystrophy in animal studies, where its inhibition led to increased muscle mass and strength.

UH gets $3.3 million funding from Cancer Prevention and Research Institute of Texas

The University of Houston has received $3.3 million from the Cancer Prevention and Research Institute of Texas.

Direct Supply to distribute GE QuietCare

GE Healthcare, a unit of GE announced today that it has entered into a distribution agreement for its flagship Home Health technology, GE QuietCare®, with Direct Supply Inc., a leading provider of eldercare equipment, eCommerce and service solutions to senior living facilities. Direct Supply will distribute and co-market GE QuietCare across the United States.

Study finds differences and similarities between iPSCs and cancer cells

UC Davis investigators have found new evidence that a promising type of stem cell now being considered for a variety of disease therapies is very similar to the type of cells that give rise to cancer. The findings suggest that although the cells - known as induced pluripotent stem cells (iPSCs) - show substantial promise as a source of replacement cells and tissues to treat injuries, disease and chronic conditions, scientists and physicians must move cautiously with any clinical use because iPSCs could also cause malignant cancer.

Alexion's Soliris Phase 2 clinical study for aHUS meets primary, secondary endpoints

Alexion Pharmaceuticals, Inc. announced today that a Phase 2 clinical study investigating Soliris (eculizumab) as a treatment for patients with atypical Hemolytic Uremic Syndrome (aHUS) who are resistant to plasma therapy met primary and key secondary endpoints with high levels of statistical and clinical significance, according to results presented today at the American Society of Nephrology (ASN) annual meeting in Denver.

Read more Medical News

› Verified 7 days ago